1. In which situations may the Registration Board provisionally register a drug for a period of two years?
2. What is the purpose of Schedule-III of the DRAP Act?
3. What labeling requirements apply to drugs manufactured for experimental purposes?
4. What kind of offense is non-cognizable under the Drugs Act 1976?
5. What is the primary purpose of the Committee of Experts on Drug Research?
6. What is the maximum time limit for submieng an appeal to the Appellate Board after receiving a decision?
7. What is the commencement date for the Drugs (Specifications) Rules, 1978?
8. What is the main duty of a Federal Inspector?
9. What are the types of licences to manufacture drugs under Drugs Licensing, Registering & Advertising rules 1976?
10. What is the penalty for selling a drug in the finished form over and above the maximum retail price fixed by the Federal Government?
11. What is the consequence of violating the conditions of a license to import drugs or the provisions of the Act?
12. Who has the authority to physically inspect consignments of exported drugs and draw samples for testing?
13. What type of containers are ophthalmic solutions and suspensions required to be contained in?
14. What action should the Authority take in response to objections raised by the Auditor-General?
15. What is the penalty for selling a drug in the finished form over and above the maximum retail price fixed by the Federal Government?
16. What is the punishment for violating any prohibitions specified in Schedule-II of the DRAP Act?
17. What is the purpose of the Committee on Drugs Evaluation?
18. Under what conditions can the aid from the research fund be withdrawn and a clinical trial terminated?
19. Who is responsible for maintaining records of quarterly production and disposal of a drug?
20. Under Schedule-II, what is allowed in terms of distributing therapeutic goods as samples?
21. What is the penalty for a person who fails to provide information requested by the Authority?
22. Under what condition can finished drugs be imported?
23. Which power of the Inspector requires specific authorization by the Government?
24. In case of an appeal against the decision of the Registration Board rejecting an application for registration of a drug, what statement is required to be submitted?
25. Which power of the Inspector requires specific authorization by the Government?
26. According to the Drug Licensing, Registering & Advertisement rules 1976, what type of information should advertisements to physicians and health-related professionals be consistent with?
27. What are "Medical Devices" under Schedule-I?
28. What is the purpose of the Drug Regulatory Authority of Pakistan Fund?
29. Where should one portion of a sample taken by an Inspector be sent for test and analysis?
30. Under what conditions are drug advertisements to the general public generally permitted?
31. What is the purpose of The Drug Regulatory Authority of Pakistan Act, 2012?
32. What is the fee for submitting an appeal to the Appellate Board, as mentioned in the rules?
33. What form should be used for applying for the grant or renewal of a licence to manufacture drugs?
34. What action should the Authority take in response to objections raised by the Auditor-General?
35. What is the condition under which printing of labeling for therapeutic goods is allowed under Schedule-II?
36. What ethical criteria should be followed for medical drug promotion?
37. What is the Appellate Board's authority to call for the record of a case for review?
38. What is the primary focus of basic research in the context of the Drugs (Research) Rules?
39. What is the maximum period for which an Inspector can forbid a person in charge of premises from removing or dispensing therapeutic goods?
40. The Authority shall levy and collect fees for its functions at rates determined by:
41. What authority is responsible for inspecting and regulaying the manufacturing of drugs under 1976 rules?
42. What stage of investigation on human beings involves determining safety, effectiveness, and common side effects of a drug?
43. What are the conditions that the Central Licensing Board must ensure are complied with before granting or renewing a licence to manufacture drugs by way of basic or semi-basic manufacture?
44. What is the tenure of the CEO's appointment, and how many times can it be extended?
45. What is the purpose of Schedule-III of the DRAP Act?
46. According to the Drugs (Specifications) Rules, 1978, what is the requirement for ophthalmic ointments?
47. What is the purpose of the criteria regarding medical representatives?
48. Which of the following actions related to therapeutic goods is PROHIBITED under Schedule-II?
49. What must be included in the labelling and promotion of a registered drug?
50. Who serves as the ex-officio Chairman of the Appellate Board?
51. What is the penalty for a subsequent offense under Clause (1) of Schedule-III?
52. What degree qualifications are required for the competent technical staff involved in the manufacture of drugs by way of basic or semi-basic manufacture?
53. In what circumstances shall a drug not be deemed misbranded or adulterated?
54. If any difficulty arises in giving effect to any provision of the DRAP Act, who has the authority to remove the difficulty?
55. What is the punishment for violating any prohibitions specified in Schedule-II of the DRAP Act?
56. When can deviations be made from the information submitted during the registration of a drug?
57. What is the purpose of the Drug Regulatory Authority of Pakistan Fund?
58. What is the term of office for members of the Registration Board?
59. What is the short title of the rules that govern the Drugs Appellate Board?
60. Who has the power to institute a prosecution for a contravention of any provision of the DRAP Act, 2012, and The Drugs Act, 1976?
61. What is the penalty for a person who fails to provide information requested by the Authority?
62. In what type of premises should the manufacturing of drugs by way of basic or semi-basic manufacture take place?
63. What is the purpose of the Drugs (Research) Rules, 1978?
64. Who can revoke an order passed under Section 32 of the DRAP Act, 2012?
65. Who is responsible for carrying out the audit of the Authority's accounts?
66. Under what circumstance can an exporter withdraw a batch of drugs from export after being informed by the licensing authority?
67. In case an exporter's license is suspended or canceled, what recourse does the licensee have?
68. What is the punishment for a person who exports, imports, manufactures for sale, or sells any spurious therapeutic good or any unregistered therapeutic good?
69. What should an Inspector do if he finds that the therapeutic good does not contravene any provisions of the Act?
70. Which court shall try an offense punishable under the DRAP Act, 2012, and The Drugs Act, 1976?
71. Within what time frame should the Authority submit its annual report to the Federal Government?
72. What is the maximum quantity of a single drug that can be imported for personal use without exceeding the limit?
73. What is the purpose of a separate application for manufacturing drugs on more than one set of premises?
74. What does the term "batch number (or lot number)" refer to?
75. For veterinary drugs, what is the source of specifications if they are not approved by the Registration Board?
76. What is the meaning of "Reference Biotherapeutic Product (RBP)" under ScheduleI?
77. The Central Research Fund fee collected by the Authority will be utilized for:
78. In which circumstances may the Registration Board register a drug on its own motion?
79. What substances are NOT included in the definition of "Drug" under Schedule-I?
80. Which term refers to the set of operations that establish the relationship between values indicated by an instrument and known reference standards?
81. Who has the authority to make rules for carrying out the purposes of the DRAP Act 2012?
82. What is the purpose of Form 6?
83. What is the penalty for giving a false warranty in respect of any therapeutic good or applying a warranty given for another therapeutic good?
84. What is the purpose of the Central Research Fund mentioned in the Drugs Licensing, Registering & Advertising Rules 1976?
85. Who is considered an "investigator" under the Drugs (Research) Rules?
86. What is the definition of "Biological Drugs (Ready-to-fill form)" under Schedule-I?
87. Which of the following is NOT a source of financing the Drug Regulatory Authority Fund?
88. What is the penalty for a person who obstructs an Inspector in the exercise of any power conferred upon him under the Act?
89. How many members does the Policy Board consist of?
90. Who has the authority to establish the Drug Regulatory Authority of Pakistan?
91. What is the duration of a license to export drugs?
92. Which authority is responsible for issuing licences to manufacture drugs by way of repacking under section 18 of ordinance in a province?
93. Which of the following offenses punishable under Schedule-III is non-cognizable?
94. Which of the following offenses punishable under Schedule-III is non-cognizable?
95. What is the procedure for appealing the suspension or cancellation of a license under Drugs Import & Export Rules 1976?
96. What does an Inspector require from a person during a search or seizure under Schedule-V?
97. When does an Inspector need to divide a sample into three portoons instead of four?
98. If any difficulty arises in giving effect to any provision of the DRAP Act, who has the authority to remove the difficulty?
99. What does an Inspector require from a person during a search or seizure under Schedule-V?
100. What is the fee for the renewal of registration of a new drug?
